Product Information

PRAMIPEXOLE ER 0.75 MG TABLET is a generic product labeled by Vitruvias Therapeutics Inc., priced at $0.6812 per EA under NDC 69680014630. Its NADAC has been published 222 times since Apr 20, 2022.

FDA first approved this application on Jun 11, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PRAMIPEXOLE ER 0.75 MG TABLET

Pramipexole Dihydrochloride
$0.6812per EA

Strength

.75 mg/1

NDC

69680014630

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

PRAMIPEXOLE DIHYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA212797

FDA Approved

6/11/2021

TE Code

AB

On Market Since

8/27/2021

Pharmacological Classes

Dopamine Agonists
Nonergot Dopamine Agonist

Price Statistics

The NADAC for PRAMIPEXOLE ER 0.75 MG TABLET has been published 222 times since Apr 20, 2022, and over the history we have for it it has declined 91.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6812 per EA
All-time high$7.8084 (Dec 14, 2022)
All-time low$0.6812 (Oct 21, 2026)
52-week high$1.4031
52-week low$0.6812
Median price$2.2295
Average price$2.8190
Largest weekly change-71.4% (Dec 21, 2022)
Weeks tracked222
Tracking sinceApr 20, 2022

Price History

1W

0.0%

1M

-5.1%

3M

-15.5%

6M

-30.3%

1Y

-49.3%

3Y

-69.4%

5Y

N/A

All

-91.3%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 90% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PRAMIPEXOLE ER 0.75 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PRAMIPEXOLE ER 0.75 MG TABLET, manufactured by Vitruvias Therapeutics Inc., is $0.6812 per EA (NDC 69680014630), effective Nov 11, 2026.

How has the price of PRAMIPEXOLE ER 0.75 MG TABLET changed over time?

Over the history we have for it, the NADAC for PRAMIPEXOLE ER 0.75 MG TABLET has declined 91.3%. It has been tracked across 222 weekly CMS publications since Apr 20, 2022.

What are the highest and lowest recorded NADAC prices for PRAMIPEXOLE ER 0.75 MG TABLET?

Since Apr 20, 2022, the NADAC for PRAMIPEXOLE ER 0.75 MG TABLET has ranged from a low of $0.6812 (Oct 21, 2026) to a high of $7.8084 (Dec 14, 2022), with a median of $2.2295 per EA.

Are there cheaper alternatives to PRAMIPEXOLE ER 0.75 MG TABLET?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PRAMIPEXOLE 0.75 MG TABLET, is $0.0650 per EA — about 90% below PRAMIPEXOLE ER 0.75 MG TABLET.

Who manufactures PRAMIPEXOLE ER 0.75 MG TABLET?

PRAMIPEXOLE ER 0.75 MG TABLET (NDC 69680014630) is labeled by Vitruvias Therapeutics Inc., and CMS classifies it as a generic product.